Contact
Please use this form to send email to PR contact of this press release:
MEDERA’S SARDOCOR ANNOUNCES FDA CLEARANCE OF IND FOR FIRST-IN-HUMAN GENE THERAPY CLINICAL TRIAL FOR DMD CARDIOMYOPATHY
TO:
media@medera.bio
Medera, Inc.